Scientists Discover New Drug Target To Prevent Alzheimer's

by VR Sreeraman on  February 15, 2009 at 11:09 AM Research News
RSS Email Print This Page Comment
 Scientists Discover New Drug Target To Prevent Alzheimer's
Scientists at the Flanders Institute for Biotechnology (VIB) claim that they have discovered a potential therapeutic target for Alzheimer's disease.

The team led by Amantha Thathiah, in collaboration with researchers from the biotech company Galapagos, have identified a protein called GPR3, which plays a key role in plaque build-up in the brain.

While experimenting on mice, the researchers observed that blocking GPR3 led to a reduction of the plaques.

The brains of Alzheimer's patients typically show the presence of amyloid plaques, which are abnormal accumulations of a protein (ß-amyloid) between the neurons.

Current medicines for Alzheimer's patients sustain the memory functions for a short time, but they are unable to stop the brain cells from dying off.

They are able to limit the loss of memory during the early phases of the disease.

The GPR3 protein is an important target molecule for the eventual development of a new medicine against Alzheimer's disease.

Source: ANI
SRM

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Clinical Trials - Different Phases of the trial Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.


Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive